Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DRE
Duke Realty Corp.
DRE
|
+$886M |
| 2 |
Chevron
CVX
|
+$595M |
| 3 |
Union Pacific
UNP
|
+$360M |
| 4 |
Baxter International
BAX
|
+$276M |
| 5 |
Xcel Energy
XEL
|
+$252M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$520M |
| 2 |
NXP Semiconductors
NXPI
|
+$248M |
| 3 |
Oracle
ORCL
|
+$242M |
| 4 |
Amgen
AMGN
|
+$197M |
| 5 |
Eli Lilly
LLY
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.12% |
| 2 | Technology | 7.86% |
| 3 | Healthcare | 6.8% |
| 4 | Industrials | 5.01% |
| 5 | Consumer Discretionary | 4.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4851
Genasys
GNSS
$78.3M
| $528K | ﹤0.01% |
190,494
-7,428
| -4% | -$23.2K |
|
4852
Onto Innovation
ONTO
$13.4B
| $528K | ﹤0.01% |
8,236
-21,089
| -72% | -$1.55M |
|
|
PAQCU
4853
DELISTED
Provident Acquisition Corp. Units
PAQCU
| $528K | ﹤0.01% |
52,206
| – | – |
|
4854
Graham Corp
GHM
$1.16B
| $527K | ﹤0.01% |
59,941
-3,330
| -5% | -$27.8K |
|
4855
Harvard Bioscience
HBIO
$28.5M
| $527K | ﹤0.01% |
20,571
-18,526
| -47% | -$613K |
|
|
IMDX
4856
Insight Molecular Diagnostics
IMDX
$162M
| $527K | ﹤0.01% |
36,069
-13,739
| -28% | -$238K |
|
4857
World Acceptance Corp
WRLD
$877M
| $527K | ﹤0.01% |
5,445
-15,387
| -74% | -$1.78M |
|
|
SOL
4858
DELISTED
Emeren Group
SOL
| $526K | ﹤0.01% |
+104,356
| New | +$595K |
|
4859
PUT
Alaska Air
ALK
$5.6B
| $525K | ﹤0.01% |
+13,400
| New | +$588K |
|
4860
CALL
TransDigm Group
TDG
$71.9B
| $525K | ﹤0.01% |
1,000
-200
| -17% | -$119K |
|
|
WNS
4861
DELISTED
WNS Holdings
WNS
| $524K | ﹤0.01% |
6,402
-252,358
| -98% | -$21M |
|
4862
Bristow Group
VTOL
$1.35B
| $523K | ﹤0.01% |
+22,265
| New | +$581K |
|
4863
XBP Global Holdings
XBP
$34.2M
| $523K | ﹤0.01% |
5,125
-793
| -13% | -$80.7K |
|
4864
Inogen
INGN
$182M
| $522K | ﹤0.01% |
+21,490
| New | +$593K |
|
|
ONCT
4865
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $522K | ﹤0.01% |
29,245
-35,561
| -55% | -$763K |
|
|
SCRMU
4866
DELISTED
Screaming Eagle Acquisition Corp. Unit
SCRMU
| $521K | ﹤0.01% |
53,371
-2,850,289
| -98% | -$27.8M |
|
|
BFX
4867
DELISTED
BowFlex Inc.
BFX
| $520K | ﹤0.01% |
318,714
-57,143
| -15% | -$115K |
|
|
ITQRU
4868
DELISTED
Itiquira Acquisition Corp. Unit
ITQRU
| $520K | ﹤0.01% |
52,395
-571
| -1% | -$5.65K |
|
4869
PUT
Eastman Chemical
EMN
$8.23B
| $519K | ﹤0.01% |
+7,300
| New | +$656K |
|
|
FOLD
4870
DELISTED
Amicus Therapeutics
FOLD
| $519K | ﹤0.01% |
49,704
-215,509
| -81% | -$2.4M |
|
4871
CALL
Puma Biotechnology
PBYI
$391M
| $518K | ﹤0.01% |
+218,600
| New | +$638K |
|
|
RJET
4872
Republic Airways Holdings
RJET
$990M
| $517K | ﹤0.01% |
20,887
-13,377
| -39% | -$459K |
|
|
SHYF
4873
DELISTED
The Shyft Group
SHYF
| $517K | ﹤0.01% |
25,295
+10,646
| +73% | +$248K |
|
|
AGEN
4874
Agenus
AGEN
$326M
| $516K | ﹤0.01% |
12,821
-117,737
| -90% | -$6M |
|
|
CARM
4875
DELISTED
Carisma Therapeutics
CARM
| $516K | ﹤0.01% |
60,740
-73,202
| -55% | -$997K |
|
Similar funds
Millennium Management's Q3 2022 Portfolio in Review
As of Q3 2022, Millennium Management held 7,917 positions worth $169B, up 4.9% from $161B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Millennium Management deployed $14.7B of net new capital in Q3 2022, opening 1,007 new positions and adding to 2,598 existing holdings. Its largest new stake was Rockwell Automation: 953,525 shares worth $205M.
By sector, the portfolio is most concentrated in Financials at 8.1% of assets, up from 7.6% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $520M trimmed.
- Millennium Management's largest Q3 2022 buy was Rockwell Automation: 953,525 shares worth $205M.
- Millennium Management added most to Duke Realty Corp. in Q3 2022, an estimated $886M increase.
- Millennium Management's biggest Q3 2022 reduction was Invesco QQQ Trust, cutting an estimated $520M.
- Millennium Management fully exited Coherent Inc in Q3 2022, selling an estimated $114M.
- Millennium Management's ten largest holdings make up 23% of its $169B portfolio in Q3 2022.
- Millennium Management opened 1,007 new positions and closed 906 in Q3 2022.
- Millennium Management's portfolio value rose 4.9% quarter-over-quarter to $169B.
Based on Millennium Management's 13F filing for Q3 2022, filed 14 Nov 2022.